Mirvetuximab soravtansine Antibody

SKU: orb2279099

Description

Mirvetuximab soravtansine (IMGN853) is an antibody-drug conjugate (ADC) targeting folate receptor alpha (FRα) for cancer research. It delivers a cytotoxic payload to inhibit proliferation and has demonstrated activity in preclinical models of ovarian cancer, including studies involving drug-resistant cell lines and xenograft models.

Research Area

Cell Biology

Key Properties

• Antibody Type: Inhibitor Antibody
• Target: Antibody-Drug Conjugates (ADCs),Antifolate
• Molecular Weight: 145.76 kDa
• Purity: 95.57% (May vary between batches)
• Conjugation: Unconjugated

Storage & Handling

• Storage: Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
• Concentration: 9.72 mg/mL
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

Mirvetuximab soravtansine, IMGN 853, IMGN853, IMGN-853, FRα, TAK-853

Compound Identifiers

PubChem CID

5715188